immunoglobulin G1- kappa, anti-[Homo sapiens CTLA4 (cytotoxic T-lymphocyte associated protein 4, CTLA-4, CD152)], monoclonal antibody (Firastotug)

Solid Tumor

Adagene Incmonoclonal_antibodyPhase 1Dormant

36/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 28/ 100
Competitive Position: 59/ 100

Competitive context

928 Active assets in the Solid Tumor cohort.

Asset / Sponsor	Phase	Rating
PANITUMUMAB Astellas Pharma Inc	Phase 2	BBB
GRANULOCYTE COLONY-STIMULATING FACTOR LENOGRASTIM Sanofi	Phase 4	BB
Inno-206 The First Affiliated Hospital of Soochow University	Phase 2/3	BB
DINITROGEN MONOXIDE Medical College of Wisconsin	Phase 4	BB
Glycopyrrolate Medical College of Wisconsin	Phase 4	BB

View all 50 →

Same molecule, other indications

immunoglobulin G1- kappa, anti-[Homo sapiens CTLA4 (cytotoxic T-lymphocyte associated protein 4, CTLA-4, CD152)], monoclonal antibody (Firastotug) is also rated in:

Advanced/Metastatic Solid TumorsDormant

CCC

Indicative ·

48 / 100

View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →